Pain Perception: on Relationships Between Dental Anxiety and Olfaction
NCT ID: NCT05369936
Last Updated: 2022-05-11
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
350 participants
INTERVENTIONAL
2018-03-12
2021-01-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
"Pain and Emotional Changes on Relationships Between Anxiety and Olfaction"
NCT06066073
The Effect of Damask Rose Essential Oil Aromatherapy on Dental Anxiety and Pain on Children
NCT06139640
The Efficacy of Lavender and Chamomile Essential Oils Inhalation in Management of Dental Anxiety and Pain in Children Undergoing Local Anesthesia Administration and Primary Tooth Extraction
NCT06133868
The Effects of Sandalwood Aromatherapy on Anxiety Levels of Pediatric
NCT05908981
Effects of Aromatherapy on Anxiety and Pain During Dental Treatment in Adults
NCT06347679
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
PREVENTION
QUADRUPLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Lavender group
On the day of the lavender group, after filling the first phase questionnaire, 20 drops of the lavender oil will be added to the electrical aromatherapy vaporizer near the patient's chair at a distance of 20 cm in the waiting room. After 20 minutes, the second phase questionnaire will be given to the patient, and then the patient will be transformed to dental clinics in which the lavender vaporizer will be placed near the dental unit at a distance of 20 cm. The vaporizer will be also prepared by adding 20 drops of the lavender which will be added added every 20 minutes until the dental sitting will be finalized, and the third questionnaire will be answered. At home, the patients will be asked to pour 3 drops of the lavender on a pad and inhale it for 5 minutes from 10 cm distance every one hour until they attend on the next day to answer the fourth questionnaire.
Aromatherapy
Lavender will be inhaled through three phases
Placebo group
The plain distal water vapors will be used as placebo, the good ventilation of the waiting room and clinics will be performed to ensure that the lavender scent is completely removed from the environment. The patients will inhale the vapors of the plain distal water
Placebo
Vapors of the distal water will be inhaled through three phases
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Aromatherapy
Lavender will be inhaled through three phases
Placebo
Vapors of the distal water will be inhaled through three phases
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
2. Attending morning sessions of clinics (9 am)
3. Liable for administration of local anesthesia, tooth preparation either for filling procedures or crown preparations, endodontic treatment, teeth extraction, or subgingival scaling
Exclusion Criteria
2. Females who had allergies, bronchial asthma, common cold, pulmonary diseases, migraine, or taking antidepressants, anxiolytic drugs, opioids, or other medications that affect our results
19 Years
25 Years
FEMALE
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Qassim University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Ghada Khalifa
Professor of Maxillofacial Surgery and Diagnostic Science
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Sarah AM Alkanan, Resident
Role: PRINCIPAL_INVESTIGATOR
Qusaiba Hospital, Qassim, Saudi Arabia
Hadeel S Alhaweri, Resident
Role: PRINCIPAL_INVESTIGATOR
Aljarirr Alshamali primary health care center, Qassim, Saudi Arabia
Ghada A Khalifa, Professor
Role: STUDY_DIRECTOR
College of Dentistry, Qassim University, Saudi Arabia
Shaimaa MS Ata, Lecturer
Role: STUDY_CHAIR
College of Dentistry, Qassim University, Saudi Arabia
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Ghada Amin Khalifa
Buraidah, Buraydah, Saudi Arabia
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
EA/3006/20018
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.